ArticleHuman gene therapy methods2013

Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy.

Christian Brendel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.